Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients
Completed
- Conditions
- Infection in ICU
- Registration Number
- NCT00543894
- Lead Sponsor
- AstraZeneca
- Brief Summary
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
-
Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
-
Hospital-acquired infections accounting for eligibility are:
- nosocomial pneumonia (including ventilator-associated pneumonia)
- bacteremia
- intra-abdominal infections
- urosepsis
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method